Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

China Medical Buys Company to Add ECLIA Testing Products

publication date: Nov 26, 2007

China Medical will spend $28.8 million to acquire Beijing Bio-Ekon Biotechnology Co. Ltd., which develops and sells advanced in-vitro diagnostic (IVD) products. China Medical did not disclose revenue/profit figures for Beijing Bio-Ekon, but the company did say the acquisition would be accretive from the quarter ending March 31, 2008. In 2006, BBE launched the product that seems to be China Med’s chief reason for the acquisition: a semi-automatic ECLIA analyzer and related reagents. China Med is also heavily involved in the ECLIA business. More details..

Stock Symbol: (NSDQ: CMED)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here